Altimmune

Altimmune Debt/EBITDA

The Total Debt to EBITDA Ratio of Altimmune (ALT) as of Nov 19, 2026 is -0.38. In the previous year, Total Debt to EBITDA Ratio was -0.02 — a change of 2,218.12% (lower).

Debt/EBITDA

-0.38

YoY

2,218.12%

Last updated:

Total Debt to EBITDA Ratio of Altimmune is 2025 -0.38 . Total Debt to EBITDA Ratio of Altimmune was 2024 -0.02 . It decreases by 2,218.12% lower compared to the previous year.

The Altimmune Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
-0.04 USD
Jan 1, 2019
-0.10 USD
Jan 1, 2020
-0.04 USD
Jan 1, 2021
-0.02 USD
Jan 1, 2022
-0.01 USD
Jan 1, 2023
-0.01 USD
Jan 1, 2024
-0.02 USD
Jan 1, 2025
-0.38 USD
The Altimmune Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.38+2,218.12%
-0.02+132.93%
-0.01-45.40%
-0.01-33.47%
-0.02-51.76%
-0.04-59.95%
-0.10+121.51%
-0.04-49.42%
-0.09-49.68%
-0.18-46.74%
-0.33+346.68%
-0.07—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

Total Debt to EBITDA Ratio of Altimmune is -0.38 in 2025.

Total Debt to EBITDA Ratio of Altimmune changed from -0.02 to -0.38, representing a 2,218.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Altimmune since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Altimmune with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Altimmune

All Key Metrics — Altimmune